Agitation Archives - Page 2 of 6

Combating Agitation In Alzheimer’s Dementia: Real World Approaches

Downloadable Resource November 7, 2023

Agitation in Alzheimer’s dementia worsens the impact of an already devastating and burdensome disease. It is associated with substantial patient burden and long term consequences. Read More

Agitation Associated With Alzheimer’s Dementia (AAD): A Focus On Stigma

Infographic September 8, 2023

In March 2023, we launched a survey of PsychU members to assess the stigma associated with AAD. This infographic summarizes the results of the survey. Over a 30-day period, 194… Read More

Agitation Associated With Alzheimer’s Dementia: Mechanism Of Disease

Video May 16, 2023

Research has shown that in patients with Alzheimer’s dementia, agitation is associated with tau pathology and neurodegeneration in the prefrontal cortex and amygdala regions of the brain. Read More

Beyond Memory Loss: Optimizing The Role Of Primary Care In Assessing & Treating Agitation In Alzheimer’s Dementia

On-Demand Webinar May 11, 2023

This webinar dives into the unmet needs within this patient population and feature experts in the management of AAD within the primary care setting. Specifically, presenters review the prevalence of… Read More

Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia

On-Demand Webinar January 11, 2023

In this webinar, the speakers will review the burden of AAD, then discuss current treatment recommendations and unmet needs. Read More

Atypical Antipsychotics Bind To A Variety Of Neurotransmitter Receptors

Downloadable Resource November 18, 2022

An illustrative representation of different atypical antipsychotics and respective binding affinities are present in this graphic. The size of the circles indicates the level of binding affinity to each receptor… Read More

Pathophysiology Of Agitation Associated with Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter Systems

On-Demand Webinar October 26, 2022

Tau pathology and neurodegeneration in key prefrontal and subcortical brain regions may increase the risk of developing agitation in Alzheimer’s dementia. Read More

Agitation

Combating Agitation In Alzheimer’s Dementia: Real World Approaches

Agitation Associated With Alzheimer’s Dementia (AAD): A Focus On Stigma

Agitation Associated With Alzheimer’s Dementia: Mechanism Of Disease

Beyond Memory Loss: Optimizing The Role Of Primary Care In Assessing & Treating Agitation In Alzheimer’s Dementia

Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia

Atypical Antipsychotics Bind To A Variety Of Neurotransmitter Receptors

Pathophysiology Of Agitation Associated with Alzheimer’s Dementia: The Potential Role Of The Norepinephrine, Serotonin, & Dopamine (NSD) Neurotransmitter Systems

Antipsychotic-Related Stigma & The Impact On Treatment Choices

Diagnosing & Assessing Agitation In Alzheimer’s Dementia

A Caregiver’s Guide To Addressing Cognitive Impairment In Mental Health

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: